Patent details

Basic Information

Publication number:

EP0566226

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP933002701

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Quinazoline derivatives.

French Title of Invention:

Dérivés de quinazoline.

German Title of Invention:

Chinazolinderivate.

SPC Number:

Dates

Filing date:

15/01/1993

Grant date:

08/11/1995

EP Publication Date:

08/11/1995

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/10/1993

EP B1 Publication Date:

08/11/1995

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/01/2013

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/12/2000

 

 

Name:

ASTRAZENECA AB

Address:

VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

History of Owners

From:

15/01/1993

To:

10/12/2000

Name:

ZENECA LIMITED

Address:

STANHOPE GATE 15, LONDON W1Y 6LN, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/11/1995

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

Barker Andrew John, Zeneca Pharmaceuticals

Address:

United Kingdom (GB)

Priority

1

Priority Number:

9201095

Priority Date:

20/01/1992

Priority Country:

United Kingdom (GB)

2

Priority Number:

9213572

Priority Date:

26/06/1992

Priority Country:

United Kingdom (GB)

3

Priority Number:

9223735

Priority Date:

12/11/1992

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 239/94;

Filing date	Document type	Number of pages